U.S. Capital Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,796
| Closed | -$237K | – | 860 |
|
|
2024
Q4 | $237K | Buy |
1,796
+344
| +24% | +$45.5K | 0.01% | 734 |
|
|
2024
Q3 | $211K | Buy |
+1,452
| New | +$211K | 0.01% | 660 |
|
|
2024
Q2 | – | Sell |
-1,664
| Closed | -$228K | – | 693 |
|
|
2024
Q1 | $228K | Sell |
1,664
-675
| -29% | -$92.6K | 0.01% | 620 |
|
|
2023
Q4 | $318K | Sell |
2,339
-932
| -28% | -$127K | 0.01% | 541 |
|
|
2023
Q3 | $400K | Sell |
3,271
-680
| -17% | -$83.2K | 0.02% | 466 |
|
|
2023
Q2 | $502K | Sell |
3,951
-2,592
| -40% | -$329K | 0.02% | 440 |
|
|
2023
Q1 | $845K | Sell |
6,543
-426
| -6% | -$55K | 0.04% | 333 |
|
|
2022
Q4 | $915K | Buy |
6,969
+4,399
| +171% | +$578K | 0.04% | 341 |
|
|
2022
Q3 | $301K | Sell |
2,570
-74
| -3% | -$8.67K | 0.02% | 515 |
|
|
2022
Q2 | $311K | Sell |
2,644
-2,527
| -49% | -$297K | 0.01% | 545 |
|
|
2022
Q1 | $674K | Buy |
5,171
+1,985
| +62% | +$259K | 0.02% | 453 |
|
|
2021
Q4 | $486K | Buy |
3,186
+57
| +2% | +$8.7K | 0.02% | 518 |
|
|
2021
Q3 | $506K | Buy |
+3,129
| New | +$506K | 0.02% | 507 |
|